Litcius/Paper detail

1211P A multicenter phase II study of atezolizumab monotherapy following definitive chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma (EPOC1802)

H. Bando, S. Kumagai, D. Kotani, M. Saori, T. Habu, T. Tsushima, Harneet K. Hara, S. Kadowaki, K. Kato, K. Chin, K. Yamaguchi, S-I. Kageyama, H. Hojo, M. Nakamura, H. Tachibana, M. Wakabayashi, M. Fukutani, Nozomu Fuse, H. Nishikawa, T. Kojima

2022Annals of Oncology15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineAtezolizumabChemoradiotherapyEsophageal squamous cell carcinomaOncologyPhases of clinical researchInternal medicineCarcinomaChemotherapyCancerPembrolizumabImmunotherapyEsophageal Cancer Research and TreatmentCancer Immunotherapy and Biomarkers